Neurology
Brain & nervous system clinical trials
Conditions of the brain, spinal cord, and nerves — including stroke, dementia, and movement disorders. We’re tracking 12,516 recruiting studies in this area right now.
By phase
- Not applicable9,855
- Phase 2786
- Phase 1573
- Phase 3533
- Phase 4344
- Phase 1/Phase 2305
- Phase 2/Phase 3120
Top conditions
- Stroke852
- Parkinson Disease423
- Alzheimer Disease341
- Multiple Sclerosis340
- Dementia230
- Ischemic Stroke202
- Epilepsy197
- Insomnia156
- Obstructive Sleep Apnea156
- Traumatic Brain Injury156
- Spinal Cord Injuries152
- Sarcopenia151
- Acute Ischemic Stroke141
- Cerebral Palsy129
- Mild Cognitive Impairment128
- Migraine112
- Pain Management112
- Amyotrophic Lateral Sclerosis106
Leading sponsors
- Beijing Tiantan Hospital134
- Riphah International University127
- Assistance Publique - Hôpitaux de Paris112
- Mayo Clinic98
- Xuanwu Hospital, Beijing94
- VA Office of Research and Development92
- Hospices Civils de Lyon80
- Johns Hopkins University71
- National Taiwan University Hospital71
- University of Minnesota65
Where studies are running
- California678
- Massachusetts307
- New York295
- Florida274
- Texas271
- Maryland245
- Alabama214
- Arizona209
- Illinois193
- Pennsylvania177
Recruiting studies12,514 total
- NCT06614582Enrolling by invitation
Long-term nose tube study for children with weak muscle tone
This study looks at the long-term safety and effectiveness of a nose tube (nasopharyngeal airway) for children who have obstructive sleep apnea due to weak muscle tone. It's for children who already used this device in a previous study.
Ann Arbor, MichiganAges 3–23 - NCT06613282Enrolling by invitation
Brain stimulation safety study in healthy volunteers
This early-phase trial tests a combination of two non-invasive brain stimulation techniques (LI-TMS and AVS) in healthy people to see if they are safe and well-tolerated. It is a first step before studying these treatments for stroke recovery.
Novosibirsk, Novosibirsk OblastAges 35–65 - NCT06606340Enrolling by invitation
Long-term study of eteplirsen, golodirsen, or casimersen for DMD
This study follows people with Duchenne muscular dystrophy (DMD) who are taking eteplirsen, golodirsen, or casimersen. It aims to understand how these medicines work in everyday life over a long period.
Little Rock, ArkansasAges Any age - NCT06605612Enrolling by invitation
Falls risk test for people with muscle and nerve conditions
This study is creating a test to predict falls in people with neuromuscular disorders. You will fill out a questionnaire about your fall risk.
München, BavariaAges 18–65 - NCT06603987Enrolling by invitationPhase 1/Phase 2
Testing a new drug combination for recurrent solid tumors
This early-phase trial tests a new combination of drugs (CICS-1 and SPM-011) along with a special imaging scan to see if they can help people with hard-to-treat cancers that have come back. It may be an option if standard treatments are no longer working.
Osaka, OsakaAges 18–85 - NCT06597071Enrolling by invitation
Eye movement test to help diagnose Parkinson's-like conditions
This study uses a simple eye-tracking test to see if eye movement patterns can help tell the difference between Parkinson's disease and similar conditions like PSP or MSA. It aims to find a faster, easier way to diagnose these disorders.
SevilleAges 30–80 - NCT06591442Enrolling by invitation
Spinal Fusion Recovery in Older Adults
This study is looking at how older adults recover after spinal fusion surgery, a type of back surgery that connects bones in the spine. The goal is to find factors that help people heal faster and feel better afterward.
Wuhan, HubeiAges 60 years+ - NCT06588803Enrolling by invitation
Long-term follow-up after EXG001-307 for type 1 SMA
This study follows up on patients with type 1 spinal muscular atrophy (SMA) who already received the EXG001-307 gene therapy in a previous trial. The goal is to monitor their long-term health and safety over time.
Shanghai, Shanghai MunicipalityAges 1 month+ - NCT06586320Enrolling by invitation
Eye movement test for Parkinson's and Essential tremor
This study uses a simple eye movement test to see if it can help tell the difference between Parkinson's disease, Essential tremor, and healthy people. The goal is to find a better way to diagnose and track these conditions.
Manchester, New HampshireAges 18 years+ - NCT06583395Enrolling by invitation
Meditation retreat study with fitness tracker
This trial studies people attending a 7-day meditation retreat to see how meditation affects well-being. You will wear a fitness tracker and answer surveys.
Palm Desert, CaliforniaAges 21 years+ - NCT06581185Enrolling by invitation
Long-term headache outcomes in childhood pseudotumor cerebri
This trial is studying how headaches from pseudotumor cerebri (a condition of increased pressure around the brain) change over 10 years in people who were diagnosed as children. It might help doctors understand the long-term effects of this condition.
HaifaAges Any age - NCT06578117Enrolling by invitation
Visual training for stroke-related vision loss
This study tests whether a computer-based visual training program can help people who have lost vision after a stroke to their brain's visual center. You must have been in a prior study with the same team.
Rochester, New YorkAges 21–75 - NCT06572332Enrolling by invitation
Brain scan study for sleep in older Chinese adults
This study uses brain scans to understand sleep problems in older Chinese adults. If you are 60+ and have trouble sleeping, you may help researchers find better ways to improve sleep.
Hong KongAges 50–90 - NCT06571565Enrolling by invitationEarly Phase 1
Manual lymph drainage for fibromyalgia patients
This trial tests whether manual lymph drainage (a gentle massage technique that helps move fluid in the body) can help reduce pain and other symptoms in women with fibromyalgia. It may offer a new, drug-free option to feel better.
Adana, çukurovaAges 25 years+ - NCT06570109Enrolling by invitation
Risk and outcomes of frailty in Alzheimer's dementia
This study looks at how frailty affects people newly diagnosed with Alzheimer's dementia. It aims to understand risk factors and outcomes to help improve care.
AalborgAges 65 years+ - NCT06566820Enrolling by invitationPhase 3
Long-term follow-up for sleep apnea study
This is a follow-up study for people with obstructive sleep apnea who have already completed two prior studies with the same medicine. The goal is to keep tracking your health and the medicine's effects over a longer time.
Birmingham, AlabamaAges 18 years+ - NCT06551727Enrolling by invitation
Stroke progression treatment: blood pressure and antiplatelet therapy
This trial tests a combination of blood pressure control and antiplatelet therapy for people whose stroke symptoms are getting worse. It is looking for those without a large brain artery clot or heart-related cause.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT06549400Enrolling by invitationPhase 3
Study on long-term safety of mexiletine for myotonic dystrophy
This study tests if a daily capsule of mexiletine is safe and helpful over 26 weeks for people with myotonic dystrophy type 1 or 2. It's for people who finished a previous related study and want to continue treatment.
LeuvenAges 16 years+ - NCT06547762Enrolling by invitation
Hybrid rehab for kids with physical disabilities
This trial tests a hybrid approach to rehabilitation for children with physical disabilities, combining in-person and technology-based care. If your child gets outpatient therapy more than once a week and can follow instructions with your help using a computer, this might be a good fit.
JerusalemAges 3–21 - NCT06545305Enrolling by invitation
Eye problems in homocystinuria patients, 2018–2022
This study looks at eye problems in people with homocystinuria. It will review medical records from 2018 to 2022 to find out how common eye issues are and what might increase the risk.
JeddahAges 20–30 - NCT06541275Enrolling by invitation
Shrinking large brain aneurysms after treatment
This trial looks at how well large or giant brain aneurysms shrink over time after a minimally invasive procedure called endovascular intervention. It may help doctors understand which treatments lead to better long-term results.
AstanaAges 18 years+ - NCT06537050Enrolling by invitationPhase 1
Safety study of JX2105 in healthy volunteers
This study tests a new oral drug called JX2105 in healthy people to see how safe it is and how the body handles it. It is a first-in-human phase 1 trial, so participants will help find the right dose and check for any side effects.
Beijing, Beijing MunicipalityAges 18–75 - NCT06533878Enrolling by invitationPhase 1
Safety of HY209 in healthy volunteers
This study tests the safety and tolerability of a new medication called HY209 in healthy volunteers. It helps researchers understand how the drug affects the body and if it causes any side effects.
Anyang-si, Gyeonggi-doAges 19–45 - NCT06527469Enrolling by invitation
Group therapy for kids ages 7-17
This study tests a group therapy program for children ages 7 to 17 who are already in the emPOWER program. The goal is to help with strength, coordination, and social skills through fun activities.
Columbia, MissouriAges 7–17
Common questions
- How many brain & nervous system clinical trials are recruiting?
- Clin2 is tracking 12,516 recruiting neurology studies from the U.S. registry right now, out of 20,061 we cover in this area in total.
- What does “Brain & nervous system” cover here?
- Conditions of the brain, spinal cord, and nerves — including stroke, dementia, and movement disorders. We group each study into brain & nervous system based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a brain & nervous system trial near me?
- Use the search to filter brain & nervous system studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.